Mark Ringhoffer
Overview
Explore the profile of Mark Ringhoffer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
1496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bethge W, Flossdorf S, Hanke F, Schmid C, Ringhoffer M, Klein S, et al.
Haematologica
. 2024 Dec;
PMID: 39633549
We investigated the effect of center-specific variables on overall survival (OS) after allogeneic hematopoietic cell transplantation (alloHCT) in acute myeloid leukemia (AML). Eligible were adult patients reported to DRST registry...
2.
Sever M, Drozd-Sokolowska J, Gras L, Koster L, Folber F, Mielke S, et al.
Bone Marrow Transplant
. 2024 Nov;
60(2):211-219.
PMID: 39533015
Autologous hematopoietic cell transplants (auto-HCTs) remain the standard of care for transplant-eligible MM patients. The general practice has been to undergo upfront apheresis following induction to collect sufficient number of...
3.
Arslan A, Labuhn S, Sala E, Ringhoffer M, Schetelig J, Schroder T, et al.
Blood Adv
. 2024 Oct;
8(23):6104-6113.
PMID: 39368803
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the best curative treatment modality for many malignant hematologic disorders. In the absence of a matched related donor, matched unrelated donors (MUDs) and...
4.
Amann E, Gowdavally S, Tsamadou C, Platzbecker U, Sala E, Wagner-Drouet E, et al.
HLA
. 2024 Jun;
103(6):e15584.
PMID: 38932717
MICA polymorphisms have been associated with increased incidence of acute GvHD and adverse outcome in allogeneic haematopoietic stem cell transplantation (HSCT). MICB is another expressed member of MHC class I-related...
5.
Jaramillo S, Le Cornet L, Kratzmann M, Krisam J, Gorner M, Hanel M, et al.
Trials
. 2023 Sep;
24(1):591.
PMID: 37715270
Background: About 50% of older patients with acute myeloid leukemia (AML) fail to attain complete remission (CR) following cytarabine plus anthracycline-based induction therapy. Salvage chemotherapy regimens are based on high-dose...
6.
Schubert M, Schmitt A, Huckelhoven-Krauss A, Neuber B, Kunz A, Waldhoff P, et al.
J Hematol Oncol
. 2023 Jul;
16(1):79.
PMID: 37481608
Background: Third-generation chimeric antigen receptor (CAR)-engineered T cells (CARTs) might improve clinical outcome of patients with B cell malignancies. This is the first report on a third-generation CART dose-escalating, phase-1/2...
7.
Dohner H, Weber D, Krzykalla J, Fiedler W, Kuhn M, Schroeder T, et al.
Lancet Haematol
. 2023 May;
10(7):e495-e509.
PMID: 37187198
Background: Acute myeloid leukaemia with mutated NPM1 is associated with high CD33 expression and intermediate-risk cytogenetics. The aim of this study was to evaluate intensive chemotherapy with or without the...
8.
Gowdavally S, Tsamadou C, Platzbecker U, Sala E, Valerius T, Klein S, et al.
Transplant Cell Ther
. 2023 May;
29(7):457.e1-457.e10.
PMID: 37150297
Previous studies have illustrated associations between the presence of activating killer cell immunoglobulin-like receptor (KIR) genes and lower susceptibility to hematologic malignancies in humans. In addition, favorable hematopoietic stem cell...
9.
Tsamadou C, Gowdavally S, Platzbecker U, Sala E, Valerius T, Wagner-Drouet E, et al.
Bone Marrow Transplant
. 2022 Jul;
57(10):1539-1547.
PMID: 35804057
A common genetic variant within the T cell receptor alpha (TCRA)-T cell receptor delta (TCRD) locus (rs2204985) has been recently found to associate with thymic function. Aim of this study...
10.
Neuchel C, Gowdavally S, Tsamadou C, Platzbecker U, Sala E, Wagner-Drouet E, et al.
HLA
. 2022 Jul;
100(4):349-360.
PMID: 35799419
Introduction: Graft-versus-host disease (GvHD) is a major complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and is highly influenced by the degree of HLA matching between recipient and donor. The...